These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6344870)

  • 1. Tissue distribution of captopril, reducible captopril conjugates and S-methylcaptopril in the rat.
    Drummer OH; Worland PJ; Jarrott B
    Biochem Pharmacol; 1983 May; 32(10):1563-8. PubMed ID: 6344870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-methylation of captopril. Demonstration of captopril thiol methyltransferase activity in human erythrocytes and enzyme distribution in rat tissues.
    Drummer OH; Miach P; Jarrott B
    Biochem Pharmacol; 1983 May; 32(10):1557-62. PubMed ID: 6344869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril disulfide conjugates may act as prodrugs: disposition of the disulfide dimer of captopril in the rat.
    Drummer OH; Jarrott B
    Biochem Pharmacol; 1984 Nov; 33(22):3567-71. PubMed ID: 6095854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition and metabolism of the novel antihypertensive agent alacepril in rats.
    Matsumoto K; Miyazaki H; Fujii T; Yoshida K; Amejima H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):40-6. PubMed ID: 3513776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined gas chromatographic-mass spectrometric procedure for the measurement of captopril and sulfur-conjugated metabolites of captopril in plasma and urine.
    Drummer OH; Jarrott B; Louis WJ
    J Chromatogr; 1984 Jan; 305(1):83-93. PubMed ID: 6368577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of a S-methyl metabolite of captopril in patients undergoing chronic captopril therapy.
    Drummer OH; Jarrott B; Louis WJ
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():81-6. PubMed ID: 6754187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril: pharmacology, metabolism and disposition.
    Migdalof BH; Antonaccio MJ; McKinstry DN; Singhvi SM; Lan SJ; Egli P; Kripalani KJ
    Drug Metab Rev; 1984; 15(4):841-69. PubMed ID: 6437780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.
    Nambu K; Matsumoto K; Takeyama K; Hosoki K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):47-51. PubMed ID: 3006710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug protein conjugates--I. A study of the covalent binding of [14C]captopril to plasma proteins in the rat.
    Park BK; Grabowski PS; Yeung JH; Breckenridge AM
    Biochem Pharmacol; 1982 May; 31(9):1755-60. PubMed ID: 7049181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies on the metabolic pathway of SQ 14225 (Captopril) and mechanism of mixed disulfide formation.
    Komai T; Ikeda T; Kawai K; Kameyama E; Shindo H
    J Pharmacobiodyn; 1981 Sep; 4(9):677-84. PubMed ID: 7038090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of 14C- and 35S-captopril in rats after intravenous and oral administration.
    Heald AF; Ita CE; Singhvi SM; Migdalof BH
    Xenobiotica; 1985 Jan; 15(1):51-6. PubMed ID: 3885586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-protein conjugates--IV. The effect of acute renal failure on the disposition of [14C]captopril in the rat.
    Yeung JH; Breckenridge AM; Park BK
    Biochem Pharmacol; 1983 Sep; 32(17):2467-72. PubMed ID: 6351864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of captopril-L-cysteine, a captopril metabolite, in rats and dogs.
    Kripalani KJ; Dean AV; Migdalof BH
    Xenobiotica; 1983 Dec; 13(12):701-5. PubMed ID: 6372264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrofluorometric determination of captopril plus captopril disulfide metabolites in plasma.
    Ivashkiv E
    J Pharm Sci; 1984 Oct; 73(10):1427-30. PubMed ID: 6389826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of captopril in blood and captopril and its disulfide metabolites in plasma by gas chromatography.
    Bathala MS; Weinstein SH; Meeker FS; Singhvi SM; Migdalof BH
    J Pharm Sci; 1984 Mar; 73(3):340-4. PubMed ID: 6371216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of the disulfide of captopril in subcellular fractions of rat tissues.
    Lan SJ; Weinstein SH; Migdalof BH
    Drug Metab Dispos; 1982; 10(4):306-11. PubMed ID: 6126325
    [No Abstract]   [Full Text] [Related]  

  • 17. Disposition of captopril in normal subjects.
    Kripalani KJ; McKinstry DN; Singhvi SM; Willard DA; Vukovich RA; Migdalof BH
    Clin Pharmacol Ther; 1980 May; 27(5):636-41. PubMed ID: 6989546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril and MK-421: stability on storage, distribution to the central nervous system, and onset of activity.
    Cohen ML; Kurz K
    Fed Proc; 1983 Feb; 42(2):171-5. PubMed ID: 6295820
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution of captopril to foetuses and milk of rats.
    Ita CE; Singhvi SM; Heald AF; Migdalof BH
    Xenobiotica; 1982 Oct; 12(10):627-32. PubMed ID: 6760566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of total captopril in human plasma by gas chromatography-mass spectrometry with selected-ion monitoring after reduction of disulfides.
    Ivashkiv E; McKinstry DN; Cohen AI
    J Pharm Sci; 1984 Aug; 73(8):1113-7. PubMed ID: 6387083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.